Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $16
Dentsply Sirona Analyst Ratings
Express News | Dentsply Sirona Inc : Piper Sandler Cuts Target Price to $16 From $20
BofA Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $16
Q4 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
Mizuho Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $16
DENTSPLY SIRONA Insiders Added US$860.4k Of Stock To Their Holdings
Morgan Stanley Downgrades Dentsply Sirona(XRAY.US) to Hold Rating, Cuts Target Price to $14
Sector Update: Health Care Stocks Retreat Late Afternoon
Sector Update: Health Care
Morgan Stanley Downgrades DENTSPLY SIRONA to Equalweight From Overweight
Leerink Partners Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY)
Express News | Dentsply Sirona Inc : Leerink Partners Cuts Target Price to $14.5 From $19
Dentsply Sirona to Host First Quarter Conference Call on May 8th
BofA Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $16
Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (CLSD), Biogen (BIIB) and DENTSPLY SIRONA (XRAY)
Insider Stock Buying Reaches US$860.4k On DENTSPLY SIRONA
Top Los Angeles Oral and Facial Surgeon, Dr. David Salehani, Hosts Exclusive Study Club Featuring Digital Dentistry Expert Dr. Storm Hagen
Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?
Express News | Dentsply Sirona Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing